A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 1 study is to characterize the pharmacokinetic profile (what the
body does to the medication) of esketamine when given by the intranasal route (through the
nose) to healthy adult Japanese and Caucasian participants.